MetLife Investment Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $963K | Sell |
56,340
-614
| -1% | -$10.5K | 0.01% | 1336 |
|
|
2025
Q1 | $3.63M | Sell |
56,954
-795
| -1% | -$50.7K | 0.02% | 771 |
|
|
2024
Q4 | $7.02M | Buy |
57,749
+4,422
| +8% | +$538K | 0.04% | 391 |
|
|
2024
Q3 | $6.66M | Sell |
53,327
-575
| -1% | -$71.8K | 0.04% | 388 |
|
|
2024
Q2 | $8.52M | Buy |
53,902
+48,462
| +891% | +$7.66M | 0.05% | 284 |
|
|
2024
Q1 | $704K | Buy |
5,440
+17
| +0.3% | +$2.2K | ﹤0.01% | 1496 |
|
|
2023
Q4 | $523K | Sell |
5,423
-74
| -1% | -$7.14K | ﹤0.01% | 1661 |
|
|
2023
Q3 | $666K | Buy |
5,497
+2
| +0% | +$242 | 0.01% | 1460 |
|
|
2023
Q2 | $629K | Buy |
5,495
+396
| +8% | +$45.4K | ﹤0.01% | 1549 |
|
|
2023
Q1 | $703K | Buy |
5,099
+12
| +0.2% | +$1.65K | 0.01% | 1433 |
|
|
2022
Q4 | $659K | Sell |
5,087
-133
| -3% | -$17.2K | 0.01% | 1470 |
|
|
2022
Q3 | $577K | Buy |
5,220
+3
| +0.1% | +$332 | ﹤0.01% | 1531 |
|
|
2022
Q2 | $391K | Sell |
5,217
-172
| -3% | -$12.9K | ﹤0.01% | 1835 |
|
|
2022
Q1 | $421K | Buy |
+5,389
| New | +$421K | ﹤0.01% | 1877 |
|
|
2019
Q2 | – | Sell |
-91
| Closed | -$10.8K | – | 2575 |
|
|
2019
Q1 | $10.8K | Hold |
91
| – | – | ﹤0.01% | 2387 |
|
|
2018
Q4 | $9.93K | Buy |
91
+4
| +5% | +$437 | ﹤0.01% | 2377 |
|
|
2018
Q3 | $14.1K | Buy |
+87
| New | +$14.1K | ﹤0.01% | 2407 |
|
|
2018
Q2 | – | Sell |
-27,646
| Closed | -$2.05M | – | 2222 |
|
|
2018
Q1 | $2.05M | Hold |
27,646
| – | – | 0.02% | 770 |
|
|
2017
Q4 | $1.54M | Buy |
+27,646
| New | +$1.54M | 0.02% | 864 |
|